Nammude Arogyam Jun 2018 | Page 14

C³Ipt_j³ ]ocnbUv (Incubation Period). AXmbXp \n] sshdÊv HcmfpsS icoc¯n {]thin¨p Ignªm tcmKe£W §Ä {]ISam¡m³ A{X bpw Znhk§Ä thWw. ]\n, XethZ\, ab¡w, XeId¡w ChbmWv BZy e£W§Ä. XpSÀ¶v cïp Znhk¯n \pÅn Xs¶ t_m[ £bapïmImw. Npa, hbdpthZ\, a\w]nc«Â, OÀZn, £oWw, ImgvN a§Â XpS§nb e£W §fpw A]qÀhambn {]ISn¸n¡mw. tcmKe£W§Ä Bcw`n¨v H¶p cïp Znhk§Ä¡Iw Xs¶ tIma AhØbnse ¯m³ km[yXbpïv. akvXnjv¡ho¡hpw XpSÀ¶pïmIp¶ XpSsc ¯pSscbpÅ A]kvamc hpamWv {][m\ k¦oÀ® 14 \½p-sS B-tcm-Kyw | Pq¬ 2018 XIÄ izmktImikw_ Ônbmb {]iv\§fmbncn ¡pw NneÀ¡v IqSpXÂ. tcmK\nÀ®bw càw, aq{Xw, sXmïbn  \n¶pw aq¡n \n¶p apÅ {ihw, Xet¨mdnse \ocmb skdnt{_m kvss]\ ^vfqbnUv F¶nhbnÂ\n¶pw dnb ssSw t]mfnatdkv sNbn³ dnbm£³ (Real time PCR) D]tbmKn¨v sshdkns\ BZy L«¯n Xs¶ thÀXncns¨Sp¯v tcmK \nÀ®bw \S¯mw. \n] sshdÊns\Xnsc icocw DXv]mZn¸n¡p¶ IgM, IgG {]Xn{Zhy§Ä AkpJw ]ptcmKan¡p¶ L«¯n Fssek ]cntim[\ bneqsS Xncn¨dnbm³ km[n¡pw. acWs¸«hcp sS AhbhtImi§fn \ns¶Sp¡p¶ km¼nfpI fn CayqtWm lntÌm sIankv{Sn ]cntim[\ \S¯n tcmKw IrXyambn \nÀ®bn¡mw. Xet¨mdn s\ _m[n¨n«ptïm F¶dnbm³ Fw BÀ sF kvIm\pw s\©nse k¦o À®XIÄ a\Ênem¡m³ FIvkv-td, Ft¡mImÀUn tbm{Kmw XpS§nb ]cn tim[\Ifpw Bhiyambn hcmw. NnInÕ 75 iXam\w hsc acW \nc¡pÅ AkpJamWv \n¸ sshdkv ]\n. \nÝnXamb NnInÕ (Specific treatment) Cà F¶v Xs¶ ]dbmw. ]e sshd tcmK§Ä¡pw sImSp¡p¶ Bânsshd acp¶mb dn_hv-dn\v (Ribavirin) acW\nc¡v 20 apX 30% hsc Ipd¡m³ IgnhpÅXmsW¶p ate jybn \S¯nb Hcp \nco£W ]T\¯n Isï¯nbn«pïv. Cu acp¶mWv Ct¸mÄ NnInÕ¡mbn D]tbmKn ¡p¶Xv. FDI /WHO AwKo Imc¯n\p thï IS¼ IÄ C\nbpw IS¶n«nÃ. `qcn]£w sshd ]\nIsft]mse Xs¶ \n] ]\nbpw Hcp kzbw \nb{´nX tcmKamWv (Self limiting). sFknbphn shânteäÀ AS¡apÅ D]IcW§fpsS klmb t¯msS tcmKnsb A]IS L«w XcWw sN¿m³ klmbn¨m acW\nc¡v 40 iXam\¯n Xmsg Ipdbv¡m\mIpw. tIcf